vs
Side-by-side financial comparison of Fortive (FTV) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× Fortive). Fortive runs the higher net margin — 12.8% vs -13.6%, a 26.4% gap on every dollar of revenue. On growth, Fortive posted the faster year-over-year revenue change (7.7% vs -5.3%). Fortive produced more free cash flow last quarter ($193.8M vs $96.0M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -17.0%).
Fortive Corporation is an American industrial technology conglomerate company headquartered in Everett, Washington. The company specializes in providing essential technologies for connected workflow solutions; designing, developing, manufacturing and distributing professional and engineered products, software and services. Their products and services are split into three strategic segments; Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. As of Decem...
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
FTV vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $136.4M | $-205.0M |
| Gross Margin | 63.2% | 49.2% |
| Operating Margin | 17.9% | -9.8% |
| Net Margin | 12.8% | -13.6% |
| Revenue YoY | 7.7% | -5.3% |
| Net Profit YoY | 21.1% | -288.1% |
| EPS (diluted) | $0.44 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.6B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.6B | $1.6B |
| Q1 26 | $136.4M | — | ||
| Q4 25 | $185.7M | $-205.0M | ||
| Q3 25 | $55.0M | $160.0M | ||
| Q2 25 | $166.6M | $145.0M | ||
| Q1 25 | $171.9M | $87.0M | ||
| Q4 24 | $208.8M | $109.0M | ||
| Q3 24 | $221.6M | $359.0M | ||
| Q2 24 | $195.1M | $195.0M |
| Q1 26 | 63.2% | — | ||
| Q4 25 | 63.2% | 49.2% | ||
| Q3 25 | 63.2% | 53.5% | ||
| Q2 25 | 59.0% | 54.8% | ||
| Q1 25 | 59.8% | 55.6% | ||
| Q4 24 | 60.3% | 56.3% | ||
| Q3 24 | 60.0% | 58.3% | ||
| Q2 24 | 59.8% | 58.4% |
| Q1 26 | 17.9% | — | ||
| Q4 25 | 20.1% | -9.8% | ||
| Q3 25 | 15.5% | 15.2% | ||
| Q2 25 | 14.6% | 14.4% | ||
| Q1 25 | 15.8% | 6.7% | ||
| Q4 24 | 19.0% | 8.1% | ||
| Q3 24 | 19.3% | 13.1% | ||
| Q2 24 | 19.4% | 14.6% |
| Q1 26 | 12.8% | — | ||
| Q4 25 | 16.5% | -13.6% | ||
| Q3 25 | 5.4% | 10.0% | ||
| Q2 25 | 11.0% | 9.1% | ||
| Q1 25 | 11.7% | 5.8% | ||
| Q4 24 | 12.9% | 6.8% | ||
| Q3 24 | 14.4% | 22.7% | ||
| Q2 24 | 12.6% | 12.1% |
| Q1 26 | $0.44 | — | ||
| Q4 25 | $0.60 | $-0.78 | ||
| Q3 25 | $0.16 | $0.61 | ||
| Q2 25 | $0.49 | $0.56 | ||
| Q1 25 | $0.50 | $0.33 | ||
| Q4 24 | $0.60 | $0.42 | ||
| Q3 24 | $0.63 | $1.38 | ||
| Q2 24 | $0.55 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $356.1M | $574.0M |
| Total DebtLower is stronger | $3.5B | $8.6B |
| Stockholders' EquityBook value | $6.1B | $752.0M |
| Total Assets | $11.6B | $12.9B |
| Debt / EquityLower = less leverage | 0.57× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $356.1M | — | ||
| Q4 25 | $375.5M | $574.0M | ||
| Q3 25 | $430.8M | $672.0M | ||
| Q2 25 | $1.8B | $599.0M | ||
| Q1 25 | $892.1M | $547.0M | ||
| Q4 24 | $813.3M | $675.0M | ||
| Q3 24 | $811.3M | $763.0M | ||
| Q2 24 | $644.1M | $704.0M |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.2B | $8.6B | ||
| Q3 25 | $3.3B | $8.8B | ||
| Q2 25 | $4.8B | $8.9B | ||
| Q1 25 | $3.9B | $9.0B | ||
| Q4 24 | $3.7B | $8.9B | ||
| Q3 24 | $3.9B | $8.7B | ||
| Q2 24 | $3.8B | $8.7B |
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.5B | $752.0M | ||
| Q3 25 | $6.5B | $906.0M | ||
| Q2 25 | $10.4B | $733.0M | ||
| Q1 25 | $10.2B | $542.0M | ||
| Q4 24 | $10.2B | $472.0M | ||
| Q3 24 | $10.6B | $493.0M | ||
| Q2 24 | $10.5B | $144.0M |
| Q1 26 | $11.6B | — | ||
| Q4 25 | $11.7B | $12.9B | ||
| Q3 25 | $11.9B | $13.6B | ||
| Q2 25 | $18.2B | $13.5B | ||
| Q1 25 | $17.1B | $13.2B | ||
| Q4 24 | $17.0B | $13.1B | ||
| Q3 24 | $17.5B | $12.8B | ||
| Q2 24 | $17.3B | $12.2B |
| Q1 26 | 0.57× | — | ||
| Q4 25 | 0.50× | 11.49× | ||
| Q3 25 | 0.51× | 9.74× | ||
| Q2 25 | 0.46× | 12.14× | ||
| Q1 25 | 0.38× | 16.52× | ||
| Q4 24 | 0.36× | 18.81× | ||
| Q3 24 | 0.37× | 17.75× | ||
| Q2 24 | 0.36× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $234.8M | $141.0M |
| Free Cash FlowOCF − Capex | $193.8M | $96.0M |
| FCF MarginFCF / Revenue | 18.1% | 6.4% |
| Capex IntensityCapex / Revenue | 2.5% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $935.2M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $234.8M | — | ||
| Q4 25 | $1.1B | $141.0M | ||
| Q3 25 | $164.4M | $264.0M | ||
| Q2 25 | $311.2M | $220.0M | ||
| Q1 25 | $241.7M | $75.0M | ||
| Q4 24 | $502.2M | $390.0M | ||
| Q3 24 | $459.0M | $141.0M | ||
| Q2 24 | $308.9M | $332.0M |
| Q1 26 | $193.8M | — | ||
| Q4 25 | $313.8M | $96.0M | ||
| Q3 25 | $153.1M | $218.0M | ||
| Q2 25 | $274.5M | $181.0M | ||
| Q1 25 | $215.0M | $43.0M | ||
| Q4 24 | $465.2M | $335.0M | ||
| Q3 24 | $431.2M | $99.0M | ||
| Q2 24 | $279.7M | $300.0M |
| Q1 26 | 18.1% | — | ||
| Q4 25 | 28.0% | 6.4% | ||
| Q3 25 | 14.9% | 13.6% | ||
| Q2 25 | 18.1% | 11.4% | ||
| Q1 25 | 14.6% | 2.8% | ||
| Q4 24 | 28.7% | 21.0% | ||
| Q3 24 | 28.1% | 6.3% | ||
| Q2 24 | 18.0% | 18.7% |
| Q1 26 | 2.5% | — | ||
| Q4 25 | 2.7% | 3.0% | ||
| Q3 25 | 1.1% | 2.9% | ||
| Q2 25 | 2.4% | 2.4% | ||
| Q1 25 | 1.8% | 2.1% | ||
| Q4 24 | 2.3% | 3.5% | ||
| Q3 24 | 1.8% | 2.7% | ||
| Q2 24 | 1.9% | 2.0% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | 5.83× | — | ||
| Q3 25 | 2.99× | 1.65× | ||
| Q2 25 | 1.87× | 1.52× | ||
| Q1 25 | 1.41× | 0.86× | ||
| Q4 24 | 2.41× | 3.58× | ||
| Q3 24 | 2.07× | 0.39× | ||
| Q2 24 | 1.58× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
